Summary
This prediction ended on 23.03.17 with a price of €54.12. With a performance of 37.77% the BUY prediction by melinda was a big success. melinda has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Novan Inc | - | - | - | - |
| iShares Core DAX® | -1.553% | -0.123% | 12.654% | 57.846% |
| iShares Nasdaq 100 | -0.386% | -0.595% | 4.546% | 93.736% |
| iShares Nikkei 225® | 1.640% | 5.468% | 17.939% | 51.788% |
| iShares S&P 500 | 0.114% | -0.217% | 1.586% | 61.648% |
Comments by melinda for this prediction
In the thread Novan Inc diskutieren
folgen
Phase 3 High-End - Daten aufgrund 1Q 2017.
SB204
Akne vulgaris
Urtext
Phase 3 Top-Line-Daten aufgrund 1Q 2017.
Eine bessere Übersetzung vorschlagen
(Vom Mitglied beendet)